Delivery Order SPE2DB22D3004-SPE2DB25FRY68
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Otezla 30 mg tablets in a 60-count quantity. This competitively awarded, non-set-aside contract has a ceiling value of $23,776.76 and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The firm fixed price delivery order represents a single-transaction procurement from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) under a firm fixed-price contract valued at $16,926.05. The delivery order, which carries no set-aside designation, was competitively awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,155.49 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive set-aside contract. The award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Otezla 30 mg tablets (60-count units) valued at $16,575.87 under a firm fixed-price arrangement. The contract is non-competitive with no set-aside designation and requires completion by September 11, 2025. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) under a firm fixed-price contract valued at $1,329.74. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive delivery order executed without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a $7,891.76 delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count) on June 20, 2025, with completion scheduled for June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,436.87 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive set-aside delivery order for pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) under a firm fixed-price contract valued at $2,623.24. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $16,991.63 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 15, 2025. The delivery order was issued on September 12, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $15,593.36. Issued on August 14, 2025, this firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's capability to meet federal...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $6,654.43. This non-set-aside, competitively awarded delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Otezla, a prescription medication used primarily for dermatological and rheumatological conditions, supports the Defense Health Agency and other federal healthcare systems. This delivery order exemplifies AmerisourceBergen Drug Corp's critical role in the federal medical supply chain, fulfilling specialized pharmaceutical requirements through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/12/25 |